Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth Hormone for Children with 18q- and Abnormal Growth
NCT00134420Phase 3Completed
- Sponsor
- UT Health San Antonio
- Start
- Feb 2001
- Primary completion
- Jun 2005
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of somatropin in 18q deletion syndrome (18q-), sponsored by UT Health San Antonio. Started Feb 2001; status: completed.
02
Drugs
somatropin
03
Conditions
18q deletion syndrome (18q-)
Beyond the preview
Go deeper on NCT00134420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00134420.